Medical Transcription Billing Corp (MTBC) CFO Sells $20,938.00 in Stock

Medical Transcription Billing Corp (NASDAQ:MTBC) CFO Bill Korn sold 3,800 shares of the firm’s stock in a transaction on Monday, November 5th. The stock was sold at an average price of $5.51, for a total transaction of $20,938.00. Following the completion of the sale, the chief financial officer now owns 167,750 shares of the company’s stock, valued at $924,302.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Bill Korn also recently made the following trade(s):

  • On Wednesday, November 7th, Bill Korn sold 9,664 shares of Medical Transcription Billing stock. The stock was sold at an average price of $5.52, for a total transaction of $53,345.28.

NASDAQ:MTBC traded down $0.22 during trading hours on Wednesday, reaching $5.23. The company had a trading volume of 265,632 shares, compared to its average volume of 76,236. The stock has a market capitalization of $60.89 million, a price-to-earnings ratio of -40.23 and a beta of 1.58. Medical Transcription Billing Corp has a twelve month low of $2.11 and a twelve month high of $5.65.

Medical Transcription Billing (NASDAQ:MTBC) last posted its quarterly earnings results on Wednesday, August 8th. The technology company reported ($0.09) EPS for the quarter, hitting analysts’ consensus estimates of ($0.09). The business had revenue of $8.68 million during the quarter, compared to analysts’ expectations of $8.39 million. Medical Transcription Billing had a negative net margin of 2.73% and a positive return on equity of 2.01%. On average, research analysts forecast that Medical Transcription Billing Corp will post -0.5 EPS for the current year.

Separately, HC Wainwright set a $6.00 price target on shares of Medical Transcription Billing and gave the stock a “buy” rating in a report on Monday, August 13th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $3.92.

An institutional investor recently bought a new position in Medical Transcription Billing stock. Dimensional Fund Advisors LP purchased a new position in Medical Transcription Billing Corp (NASDAQ:MTBC) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 27,909 shares of the technology company’s stock, valued at approximately $108,000. Dimensional Fund Advisors LP owned 0.24% of Medical Transcription Billing at the end of the most recent quarter. 5.93% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “Medical Transcription Billing Corp (MTBC) CFO Sells $20,938.00 in Stock” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/11/07/medical-transcription-billing-corp-mtbc-cfo-sells-20938-00-in-stock.html.

About Medical Transcription Billing

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Further Reading: Fundamental Analysis and Individual Investors

Insider Buying and Selling by Quarter for Medical Transcription Billing (NASDAQ:MTBC)

Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply